LAMEA Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The Latin America, Middle East and Africa Clinical Nutrition Market would witness market growth of 7.9% CAGR during the forecast period (2020-2026).
Dietary therapy is critical to proper growth and development, the prevention of acute complications, and/or the prevention of long-term complications of a given disorder. Failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for people with hereditary metabolic disorders is life-long. The treatment of patients with multiple inborn metabolism mistakes includes a multidisciplinary strategy that incorporates diet and medical care.
Brazil's market dominated the region of Latin America due to an increase in the obese population and an increase in the incidence of chronic diseases. The high incidence of preterm births, contributing to a rise in demand for clinical nutrition, would benefit Brazil's market growth. In addition, a strong association with the American Society of Parenteral and Enteral Nutrition is helping to grow the country's clinical nutrition market.
The presence of associations such as the South African Society for Enteral and Parental Nutrition, creating awareness of clinical nutrition in the country, coupled with the increasing burden of disease, will drive the South African market over the forecast timeframe. Health infrastructure creation and growing efforts from both the public and private sectors to improve sales of dietary formulas throughout the country would fuel market growth.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the Study
Market Segmentation:
By Route of Administration
Dietary therapy is critical to proper growth and development, the prevention of acute complications, and/or the prevention of long-term complications of a given disorder. Failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for people with hereditary metabolic disorders is life-long. The treatment of patients with multiple inborn metabolism mistakes includes a multidisciplinary strategy that incorporates diet and medical care.
Brazil's market dominated the region of Latin America due to an increase in the obese population and an increase in the incidence of chronic diseases. The high incidence of preterm births, contributing to a rise in demand for clinical nutrition, would benefit Brazil's market growth. In addition, a strong association with the American Society of Parenteral and Enteral Nutrition is helping to grow the country's clinical nutrition market.
The presence of associations such as the South African Society for Enteral and Parental Nutrition, creating awareness of clinical nutrition in the country, coupled with the increasing burden of disease, will drive the South African market over the forecast timeframe. Health infrastructure creation and growing efforts from both the public and private sectors to improve sales of dietary formulas throughout the country would fuel market growth.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the Study
Market Segmentation:
By Route of Administration
- Oral
- Enteral and
- Parenteral
- Cancer
- Neurological Diseases
- Gastrointestinal Disorders
- Metabolic Disorders and
- Other Applications
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Nestle S.A.
- Lonza Group AG
- BASF SE
- Ajinomoto Co., Inc.
- Perrigo Company PLC
- Hero Nutritionals, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Clinical Nutrition Market, by Route of Administration
1.4.2 LAMEA Clinical Nutrition Market, by Application
1.4.3 LAMEA Clinical Nutrition Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Jan – 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions: 2016, Mar – 2019, Oct) Leading Players
CHAPTER 4. LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION
4.1 LAMEA Oral Market by Country
4.2 LAMEA Enteral Market by Country
4.3 LAMEA Parenteral Market by Country
CHAPTER 5. LAMEA CLINICAL NUTRITION MARKET BY APPLICATION
5.1 LAMEA Cancer Market by Country
5.2 LAMEA Neurological Diseases Market by Country
5.2.1.1 LAMEA Gastrointestinal Disorders Market by Country
5.3 LAMEA Metabolic Disorders Market by Country
5.4 LAMEA Other Applications Market by Country
CHAPTER 6. LAMEA CLINICAL NUTRITION MARKET BY END USER
6.1 LAMEA Adults Clinical Nutrition Market by Country
6.2 LAMEA Pediatric Market by Country
6.3 LAMEA Geriatric Market by Country
CHAPTER 7. LAMEA CLINICAL NUTRITION MARKET BY COUNTRY
7.1 Brazil Clinical Nutrition Market
7.1.1 Brazil Clinical Nutrition Market by Route Of Administration
7.1.2 Brazil Clinical Nutrition Market by Application
7.1.3 Brazil Clinical Nutrition Market by End User
7.2 Argentina Clinical Nutrition Market
7.2.1 Argentina Clinical Nutrition Market by Route Of Administration
7.2.2 Argentina Clinical Nutrition Market by Application
7.2.3 Argentina Clinical Nutrition Market by End User
7.3 UAE Clinical Nutrition Market
7.3.1 UAE Clinical Nutrition Market by Route Of Administration
7.3.2 UAE Clinical Nutrition Market by Application
7.3.3 UAE Clinical Nutrition Market by End User
7.4 Saudi Arabia Clinical Nutrition Market
7.4.1 Saudi Arabia Clinical Nutrition Market by Route Of Administration
7.4.2 Saudi Arabia Clinical Nutrition Market by Application
7.4.3 Saudi Arabia Clinical Nutrition Market by End User
7.5 South Africa Clinical Nutrition Market
7.5.1 South Africa Clinical Nutrition Market by Route Of Administration
7.5.2 South Africa Clinical Nutrition Market by Application
7.5.3 South Africa Clinical Nutrition Market by End User
7.6 Nigeria Clinical Nutrition Market
7.6.1 Nigeria Clinical Nutrition Market by Route Of Administration
7.6.2 Nigeria Clinical Nutrition Market by Application
7.6.3 Nigeria Clinical Nutrition Market by End User
7.7 Rest of LAMEA Clinical Nutrition Market
7.7.1 Rest of LAMEA Clinical Nutrition Market by Route Of Administration
7.7.2 Rest of LAMEA Clinical Nutrition Market by Application
7.7.3 Rest of LAMEA Clinical Nutrition Market by End User
CHAPTER 8. COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Partnerships, Collaborations, and Agreements:
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Geographical Expansions:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.1 Hero Nutritionals, Inc.
8.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Clinical Nutrition Market, by Route of Administration
1.4.2 LAMEA Clinical Nutrition Market, by Application
1.4.3 LAMEA Clinical Nutrition Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Jan – 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions: 2016, Mar – 2019, Oct) Leading Players
CHAPTER 4. LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION
4.1 LAMEA Oral Market by Country
4.2 LAMEA Enteral Market by Country
4.3 LAMEA Parenteral Market by Country
CHAPTER 5. LAMEA CLINICAL NUTRITION MARKET BY APPLICATION
5.1 LAMEA Cancer Market by Country
5.2 LAMEA Neurological Diseases Market by Country
5.2.1.1 LAMEA Gastrointestinal Disorders Market by Country
5.3 LAMEA Metabolic Disorders Market by Country
5.4 LAMEA Other Applications Market by Country
CHAPTER 6. LAMEA CLINICAL NUTRITION MARKET BY END USER
6.1 LAMEA Adults Clinical Nutrition Market by Country
6.2 LAMEA Pediatric Market by Country
6.3 LAMEA Geriatric Market by Country
CHAPTER 7. LAMEA CLINICAL NUTRITION MARKET BY COUNTRY
7.1 Brazil Clinical Nutrition Market
7.1.1 Brazil Clinical Nutrition Market by Route Of Administration
7.1.2 Brazil Clinical Nutrition Market by Application
7.1.3 Brazil Clinical Nutrition Market by End User
7.2 Argentina Clinical Nutrition Market
7.2.1 Argentina Clinical Nutrition Market by Route Of Administration
7.2.2 Argentina Clinical Nutrition Market by Application
7.2.3 Argentina Clinical Nutrition Market by End User
7.3 UAE Clinical Nutrition Market
7.3.1 UAE Clinical Nutrition Market by Route Of Administration
7.3.2 UAE Clinical Nutrition Market by Application
7.3.3 UAE Clinical Nutrition Market by End User
7.4 Saudi Arabia Clinical Nutrition Market
7.4.1 Saudi Arabia Clinical Nutrition Market by Route Of Administration
7.4.2 Saudi Arabia Clinical Nutrition Market by Application
7.4.3 Saudi Arabia Clinical Nutrition Market by End User
7.5 South Africa Clinical Nutrition Market
7.5.1 South Africa Clinical Nutrition Market by Route Of Administration
7.5.2 South Africa Clinical Nutrition Market by Application
7.5.3 South Africa Clinical Nutrition Market by End User
7.6 Nigeria Clinical Nutrition Market
7.6.1 Nigeria Clinical Nutrition Market by Route Of Administration
7.6.2 Nigeria Clinical Nutrition Market by Application
7.6.3 Nigeria Clinical Nutrition Market by End User
7.7 Rest of LAMEA Clinical Nutrition Market
7.7.1 Rest of LAMEA Clinical Nutrition Market by Route Of Administration
7.7.2 Rest of LAMEA Clinical Nutrition Market by Application
7.7.3 Rest of LAMEA Clinical Nutrition Market by End User
CHAPTER 8. COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Partnerships, Collaborations, and Agreements:
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Geographical Expansions:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.1 Hero Nutritionals, Inc.
8.10.1 Company Overview
LIST OF TABLES
TABLE 1 LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– CLINICAL NUTRITION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– CLINICAL NUTRITION MARKET
TABLE 5 MERGERS & ACQUISITIONS – CLINICAL NUTRITION MARKET
TABLE 6 GEOGRAPHICAL EXPANSIONS – CLINICAL NUTRITION MARKET
TABLE 7 LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 8 LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 9 LAMEA ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 LAMEA CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 LAMEA PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 LAMEA PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 LAMEA GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 LAMEA GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 BRAZIL CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 38 BRAZIL CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 39 BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 40 BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 41 BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 42 BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 43 BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 44 BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 45 ARGENTINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 46 ARGENTINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 47 ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 48 ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 49 ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 50 ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 51 ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 52 ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 53 UAE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 54 UAE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 55 UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 56 UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 57 UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 UAE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 60 UAE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 61 SAUDI ARABIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 62 SAUDI ARABIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 63 SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 64 SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 65 SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 66 SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 67 SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 68 SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 69 SOUTH AFRICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 70 SOUTH AFRICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 71 SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 72 SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 73 SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 74 SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 75 SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 76 SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 77 NIGERIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 78 NIGERIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 79 NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 80 NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 81 NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 82 NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 83 NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 84 NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 85 REST OF LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 86 REST OF LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 87 REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 88 REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 89 REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 90 REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 91 REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 92 REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 95 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 96 KEY INFORMATION – PFIZER, INC.
TABLE 97 KEY INFORMATION – NESTLE S.A.
TABLE 98 KEY INFORMATION – LONZA GROUP AG
TABLE 99 KEY INFORMATION – BASF SE
TABLE 100 KEY INFORMATION –AJINOMOTO CO., INC.
TABLE 101 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 102 KEY INFORMATION – HERO NUTRITIONALS, INC.
TABLE 1 LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– CLINICAL NUTRITION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– CLINICAL NUTRITION MARKET
TABLE 5 MERGERS & ACQUISITIONS – CLINICAL NUTRITION MARKET
TABLE 6 GEOGRAPHICAL EXPANSIONS – CLINICAL NUTRITION MARKET
TABLE 7 LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 8 LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 9 LAMEA ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 LAMEA CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 LAMEA PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 LAMEA PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 LAMEA GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 LAMEA GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 BRAZIL CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 38 BRAZIL CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 39 BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 40 BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 41 BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 42 BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 43 BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 44 BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 45 ARGENTINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 46 ARGENTINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 47 ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 48 ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 49 ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 50 ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 51 ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 52 ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 53 UAE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 54 UAE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 55 UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 56 UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 57 UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 UAE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 60 UAE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 61 SAUDI ARABIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 62 SAUDI ARABIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 63 SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 64 SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 65 SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 66 SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 67 SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 68 SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 69 SOUTH AFRICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 70 SOUTH AFRICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 71 SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 72 SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 73 SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 74 SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 75 SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 76 SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 77 NIGERIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 78 NIGERIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 79 NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 80 NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 81 NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 82 NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 83 NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 84 NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 85 REST OF LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 86 REST OF LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 87 REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 88 REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 89 REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 90 REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 91 REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 92 REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 95 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 96 KEY INFORMATION – PFIZER, INC.
TABLE 97 KEY INFORMATION – NESTLE S.A.
TABLE 98 KEY INFORMATION – LONZA GROUP AG
TABLE 99 KEY INFORMATION – BASF SE
TABLE 100 KEY INFORMATION –AJINOMOTO CO., INC.
TABLE 101 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 102 KEY INFORMATION – HERO NUTRITIONALS, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, JAN – 2019, DEC) LEADING PLAYERS
FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS: 2016, MAR – 2019, OCT) LEADING PLAYERS
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, JAN – 2019, DEC) LEADING PLAYERS
FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS: 2016, MAR – 2019, OCT) LEADING PLAYERS
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
